{"id":250494,"date":"2025-10-30T08:07:11","date_gmt":"2025-10-30T08:07:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/250494\/"},"modified":"2025-10-30T08:07:11","modified_gmt":"2025-10-30T08:07:11","slug":"bell-potter-just-upgraded-the-target-price-on-asx-healthcare-stock","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/250494\/","title":{"rendered":"Bell Potter just upgraded the target price on ASX healthcare stock"},"content":{"rendered":"

\"Research,<\/p>\n

Image source: Getty Images<\/p>\n

Broker Bell Potter has issued a new report on ASX healthcare stock<\/a> Neuren Pharmaceuticals Ltd (ASX: NEU<\/a>). <\/p>\n

It has maintained its buy rating and also increased its target price.\u00a0<\/p>\n

Neuren Pharmaceuticals is a biopharmaceutical company specialising in developing new therapies for neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells. <\/p>\n

Its share price has risen<\/a> more than 76% since January.\u00a0<\/p>\n

This has been on the back of FDA approval<\/a> on key treatments developed by the company.\u00a0<\/p>\n

Despite rising significantly already in 2025, Bell Potter sees more growth in the future for this ASX healthcare stock.\u00a0<\/p>\n

Let’s see what was behind the upgraded target.\u00a0<\/p>\n

Bell Potter says momentum expected to continue <\/p>\n

In this week’s report, Bell Potter said it expects another strong quarter of Daybue sales growth in the US.\u00a0<\/p>\n

For context, DAYBUE<\/a> (trofinetide) is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) specifically indicated for Rett syndrome in adults and pediatric patients.<\/p>\n

This growth will be driven by expanded sales coverage and more community-based patient starts.\u00a0<\/p>\n

The broker said it expects an uptick in new patient starts from the community practice setting in 2H25 (where ~65% of US Rett patients are treated). This is rather than the larger academic institutions where much of the early adoption was derived.\u00a0<\/p>\n

It also expects a growing number of longer-treated patients who have been on Daybue >12-18 months. It said this will result in greater stability in demand\/sales. <\/p>\n

Forecast Daybue sales of US$102m should generate approximately A$16m in royalties, with European approval anticipated in Q1 2026.<\/p>\n

Forecast unchanged \u2013 PT rises <\/p>\n

Bell Potter made no changes to forecasts, expecting this ASX healthcare stock to remain profitable in CY25.\u00a0<\/p>\n

The broker maintains a buy recommendation and increases its target price to $25 (previously $22) ahead of an anticipated positive Q3 Daybue update.<\/p>\n

Based on the upgraded target of $25 and today’s share price, there is almost 16% upside for the ASX healthcare stock.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Image source: Getty Images Broker Bell Potter has issued a new report on ASX healthcare stock Neuren Pharmaceuticals…\n","protected":false},"author":2,"featured_media":250495,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,137,500],"class_list":{"0":"post-250494","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-au","9":"tag-australia","10":"tag-health","11":"tag-healthcare"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/250494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=250494"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/250494\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/250495"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=250494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=250494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=250494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}